Why the study?
Cardiovascular disease is the leading cause of US maternal mortality, yet contraception can prevent mortality and morbidity from unplanned pregnancy in patients with congenital or acquired heart disease.
What are the safe and effective contraceptive methods for patients with underlying congenital or acquired heart disease based on the 2024 US Medical Eligibility Criteria?
Population
Patients with underlying congenital or acquired heart disease
Design
Review
Authors
Loading...
May guide contraceptive counseling in cardiac patients; leaves open need for prospective validation of estrogen risks.
What are the safe and effective contraceptive methods for patients with underlying congenital or acquired heart disease based on the 2024 US Medical Eligibility Criteria?
This review highlights that intrauterine devices, implants, and progestin-only contraceptives are safe and highly effective for most patients with cardiac disease, while estrogen-containing methods carry higher risks.
Shapero et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: